SAI.TECH Global Corporation (NASDAQ: SAI) has recently attracted considerable attention in the stock market. Following a 3% decline during Wednesday’s regular trading session, the stock experienced a remarkable turnaround after the closing bell. In afterhours trading, SAI surged by as much as 17.5% at one point, an impressive rebound that caught many investors’ eyes. Volume […]
SAI.TECH Global Sees Significant Afterhours Surge Read More »
Addentax Group Corp. (NASDAQ: ATXG) has recently garnered significant attention. While the stock experienced a modest 3% increase during Wednesday’s regular trading session, it soared by an impressive 26.5% in the afterhours session. This surge has left investors buzzing, despite the absence of any apparent news to justify the sudden spike.* Market Reaction and Speculation
Addentax Group Soars in Afterhours Pump and Dump Read More »
Chuy’s Holdings, Inc. (NASDAQ: CHUY) experienced a remarkable afterhours surge on Wednesday, despite showing minimal movement during regular trading hours. The stock soared by 48% following news that Darden Restaurants, Inc. (owner of the Olive Garden chain), had agreed to acquire the Tex-Mex restaurant operator. Chuy’s Acquisition Details and Market Reaction Founded in Austin, Texas
Chuy’s Holdings Surges Afterhours on Acquisition News Read More »
Shares of CytoMed Therapeutics Limited (NASDAQ: GDTC) are experiencing a significant uptick in the US stock market. As of the latest pre-market session, GDTC stock has risen by 17.65%, reaching $2.40. This surge follows the company’s announcement of multiple strategic developments. Acquisition of Cellsafe International’s Assets CytoMed, through its wholly owned subsidiary IPSC Depository Sdn
CytoMed (GDTC): Pre-Market Stock Surge Amid Strategic Moves Read More »
After announcing several clinical collaborations yesterday, ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) has witnessed a noticeable increase on the US stock charts. During Tuesday’s extended session, ORIC stock gained 9.83% in market value to trade at $12.07. Starting ORIC-944 Dosage in Combination Therapies ORIC Pharmaceuticals announced that it has started to administer ORIC-944, a strong PRC2 allosteric
ORIC Pharmaceuticals: Collaborations Drive After-Market Stock Surge Read More »
Following the announcement of a strategic acquisition on Tuesday, shares of Aehr Test Systems (NASDAQ: AEHR) displayed robust performance on the US stock charts. As of the latest check during the after-hours session, AEHR stock had surged by 13.42%, reaching $19.10, after already experiencing a 2.50% rise during the regular trading session, closing at $16.84.
Aehr Test Systems Stock Gains Momentum After Acquisition Disclosure Read More »
After unveiling a significant collaboration deal, shares of Bloom Energy Corporation (NYSE: BE) experienced a notable surge during the after-hour trading session on Tuesday. As of the last report, BE stock rose by 14.19% on the US stock charts, reaching $17.22. Bloom Energy Entered A Significant Partnership Bloom Energy (BE) announced a strategic partnership with
Significant Collaboration Propels Bloom Energy (BE) Shares After-Hours Read More »
Shares of Shimmick Corporation (NASDAQ: SHIM) experienced a substantial increase in the US stock market, particularly during the extended trading session. As of the latest after-market check, SHIM stock surged by 49.75% to $3.10, following a 12.50% rise in the regular session, where it closed at $2.07. This remarkable growth is attributed to Shimmick’s recent
Shimmick (SHIM) Stock Soars After-Hours Following Major Contract Award Read More »
Laser Photonics Corporation (NASDAQ: LASE) is witnessing a bullish surge in its stock performance as it unveils the latest addition to its product arsenal. As of the latest pre-market assessment, LASE stock has surged by 7.07% to $2.12, marking a significant uptick on the US stock charts. Laser Photonics Revolutionizing Auto Industry Laser Photonics (LASE)
Bullish Trend For Laser Photonics (LASE) Stock After A Product Launch Read More »
Silo Pharma, Inc. (NASDAQ: SILO) is enjoying a pre-market spike following a significant license agreement, indicating increased investor interest. The business has obtained an exclusive global license to further the research, development, and commercialization of its Alzheimer’s medication, SPC-14. Addressing Critical Medical Needs The exclusive licensing of SPC-14 positions Silo Pharma to address a significant
Silo Pharma Shares Surge Following Licensing Agreement Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.